TeamViewer (TMV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
22 Oct, 2025Executive summary
Q3 2025 delivered 4% year-over-year revenue and ARR growth in constant currency, with pro forma ARR at €757 million and Enterprise ARR up 12% (TeamViewer standalone Enterprise ARR up 18%).
Profitability remained strong, with a 46% pro forma adjusted EBITDA margin and adjusted EPS up 15% year-over-year.
1E standalone business underperformed, with ARR down 2% and revenue down 8% year-over-year, impacted by customer churn, sales team departures, and macroeconomic headwinds.
Strategic focus shifted to product innovation, AI integration, and harmonizing go-to-market approaches post-1E acquisition, including launches in autonomous endpoint management, agentic AI, DEX Essentials, and TeamViewer ONE.
Net leverage ratio improved to 2.8x, aligning with deleveraging targets.
Financial highlights
Q3 2025 pro forma revenue was €192.0 million, up 4% year-over-year in constant currency; TeamViewer standalone revenue was €176.6 million (+6% cc yoy); 1E standalone revenue was €15.4 million (-8% cc yoy).
Pro forma adjusted EBITDA reached €87.7 million, with a 46% margin.
Pro forma adjusted EPS was €0.34, up 15% year-over-year.
Net income (IFRS) for Q3 2025 was €28.7 million, down 27% year-over-year, mainly due to negative FX effects and higher interest expenses from the 1E acquisition.
Cash flows from operating activities were €34.0 million (-29% yoy); levered free cash flow was €19.4 million (-53% yoy).
Outlook and guidance
Full-year 2025 ARR guidance revised down to €780–800 million due to slower 1E/DEX pipeline conversion and FX headwinds.
Full-year revenue guidance maintained at €778–797 million, but at the low end.
Adjusted EBITDA margin guidance raised to approximately 44% for 2025.
2026 revenue expected to grow 2–6% year-over-year, reaching €790–825 million, with €25 million FX headwinds.
Additional cost measures planned to offset topline shortfall.
Latest events from TeamViewer
- 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025